Masaki Anzai

678 total citations
26 papers, 487 citations indexed

About

Masaki Anzai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Masaki Anzai has authored 26 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 4 papers in Surgery. Recurrent topics in Masaki Anzai's work include Lung Cancer Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Research Studies (5 papers). Masaki Anzai is often cited by papers focused on Lung Cancer Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Research Studies (5 papers). Masaki Anzai collaborates with scholars based in Japan, Kyrgyzstan and Germany. Masaki Anzai's co-authors include Takashi Ishida, Naofumi Shinagawa, Akifumi Tsuzuku, Fumihiro Asano, Satoshi Morita, Yukihiro Umeda, Miwa Morikawa, Satoshi Oizumi, Joe Shindoh and Tamotsu Ishizuka and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Annals of Oncology.

In The Last Decade

Masaki Anzai

23 papers receiving 486 citations

Peers

Countries citing papers authored by Masaki Anzai

Since Specialization

Citations

This map shows the geographic impact of Masaki Anzai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Anzai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Anzai more than expected).

Fields of papers citing papers by Masaki Anzai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Anzai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Anzai. The network helps show where Masaki Anzai may publish in the future.

Co-authorship network of co-authors of Masaki Anzai

This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Anzai. A scholar is included among the top collaborators of Masaki Anzai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Anzai. Masaki Anzai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of Nanoparticle Albumin-Bound Paclitaxel (nab-PTX) Monotherapy Can Be Improved after Treatment with Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer: Long-Term Follow-Up and Updated Analysis of Two Previous Prospective Clinical Studies 2024 ·Oncology ·Koki Nakashima, Yukihiro Umeda, Yoshiki Demura, (unknown), (unknown), Makiko Yamaguchi, Masaki Anzai, Maiko Kadowaki, (unknown), (unknown), (unknown), Yuko Waseda, Tamotsu Ishizuka	3
2	Safety and utility of Endoscopic Ultrasound with Bronchoscope-guided Fine Needle Aspiration (EUS-B-FNA) in suspected lung cancer patients with poor respiratory or general conditions: a prospective three-center observational study 2023 ·BMC Pulmonary Medicine ·Koki Nakashima, Yukihiro Umeda, Yoshiki Demura, Toshihiro Takeda, (unknown), Masayuki Sato, (unknown), (unknown), (unknown), Makiko Yamaguchi, (unknown), (unknown), (unknown), Yuko Waseda, Masaki Anzai, (unknown), Tamotsu Ishizuka	8
3	Efficacy and safety of nanoparticle albumin‐bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non‐small cell lung cancer: A multicenter Phase 2 clinical trial 2023 ·Cancer Medicine ·(unknown), Yukihiro Umeda, Yoshiki Demura, (unknown), Koki Nakashima, Masaki Anzai, Makiko Yamaguchi, (unknown), (unknown), (unknown), Yuko Waseda, (unknown), Tamotsu Ishizuka	11
4	Surfactant protein D: a useful marker for differentiation of drug-induced pneumonia and bacterial pneumonia 2021 ·SHILAP Revista de lepidopterología ·Yuko Waseda, Masahide Yasui, (unknown), (unknown), Toshihiro Takeda, (unknown), (unknown), Makiko Yamaguchi, Satoshi Watanabe, Hazuki Takato, Yukari Ichikawa, Yukihiro Umeda, Masaki Anzai, Hiroshi Ueda, Kazuo Kasahara, Tamotsu Ishizuka	2
5	Predictive value of 3′-deoxy-3′-¹⁸F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer 2021 ·Journal for ImmunoTherapy of Cancer ·Masayuki Sato, Yukihiro Umeda, Tetsuya Tsujikawa, Tetsuya Mori, Miwa Morikawa, Masaki Anzai, Yuko Waseda, Maiko Kadowaki, Yasushi Kiyono, Hidehiko Okazawa, Tamotsu Ishizuka	7
6	Metal-Stimulated Interleukin-6 Production Through a Proton-Sensing Receptor, Ovarian Cancer G Protein-Coupled Receptor 1, in Human Bronchial Smooth Muscle Cells: A Response Inhibited by Dexamethasone 2021 ·Journal of Inflammation Research ·Maiko Kadowaki, Kōichi Sato, (unknown), (unknown), (unknown), (unknown), Yukihiro Umeda, Yuko Waseda, Masaki Anzai, Haruka Aoki‐Saito, Yasuhiko Koga, Takeshi Hisada, Hideaki Tomura, Fumikazu Okajima, Tamotsu Ishizuka	2
7	Predictive value of integrated ¹⁸F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer 2020 ·Journal for ImmunoTherapy of Cancer ·Yukihiro Umeda, Miwa Morikawa, Masaki Anzai, Shingo Ameshima, Maiko Kadowaki, Yuko Waseda, Hiroko Shigemi, Tetsuya Tsujikawa, Yasushi Kiyono, Hidehiko Okazawa, Tamotsu Ishizuka	22
8	The vertebral 3′-deoxy-3′-18F-fluorothymidine uptake predicts the hematological toxicity after systemic chemotherapy in patients with lung cancer 2019 ·European Radiology ·Yukihiro Umeda, Tetsuya Tsujikawa, Masaki Anzai, Miwa Morikawa, Yuko Waseda, Maiko Kadowaki, Hiroko Shigemi, Shingo Ameshima, Tetsuya Mori, Yasushi Kiyono, Hidehiko Okazawa, Tamotsu Ishizuka	5
9	Extracellular acidification-induced CXCL8 production through a proton-sensing receptor OGR1 in human airway smooth muscle cells: a response inhibited by dexamethasone 2019 ·Journal of Inflammation ·Maiko Kadowaki, Hidenori Yamada, Kōichi Sato, Hiroko Shigemi, Yukihiro Umeda, Miwa Morikawa, Yuko Waseda, Masaki Anzai, Yosuke Kamide, Haruka Aoki‐Saito, Takeshi Hisada, Fumikazu Okajima, Tamotsu Ishizuka	15
10	A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations 2018 ·Lung Cancer ·Hisao Imai, Kyoichi Kaira, Kensuke Suzuki, Masaki Anzai, (unknown), Tamotsu Ishizuka, (unknown), Ichiro Naruse, Kenji Nemoto, Junji Uchino, (unknown), Shinichi Ishihara, Koichi Minato, Takeshi Hisada	31
11	Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer 2018 ·International Journal of Clinical Oncology ·(unknown), Ryoichi Yano, (unknown), (unknown), Shinji Yamashita, (unknown), Kyohei Watanabe, (unknown), Toshiaki Nakamura, Maiko Kadowaki, Miwa Morikawa, Yukihiro Umeda, Masaki Anzai, Tamotsu Ishizuka, Nobuyuki Goto	5
12	P2.02-024 Phase I and II Trial of Intrapleural Paclitaxel Injection for Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusions 2017 ·Journal of Thoracic Oncology ·Masato Sasaki, (unknown), (unknown), Masaki Anzai, Miwa Morikawa, Yukihiro Umeda, Shingo Ameshima, Tamotsu Ishizuka, Takaaki Koshiji	1
13	Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy as second-line therapy of cytotoxic anticancer drugs in patients with advanced non-small cell lung cancer 2017 ·Medicine ·Masaki Anzai, Miwa Morikawa, (unknown), Yukihiro Umeda, Yoshiki Demura, (unknown), Makiko Yamaguchi, (unknown), (unknown), Shingo Ameshima, (unknown), Tamotsu Ishizuka	13
14	Virtual bronchoscopic navigation without X-ray fluoroscopy to diagnose peripheral pulmonary lesions: a randomized trial 2017 ·BMC Pulmonary Medicine ·Fumihiro Asano, Takashi Ishida, Naofumi Shinagawa, Noriaki Sukoh, Masaki Anzai, Kenya Kanazawa, Akifumi Tsuzuku, Satoshi Morita	33
15	Blunted Activation of Rho-Kinase in Yak Pulmonary Circulation 2015 ·BioMed Research International ·Takeshi Ishizaki, Shiro Mizuno, Akio Sakai, Shigeru Matsukawa, Baktybek Kojonazarov, (unknown), Yukihiro Umeda, Miwa Morikawa, Masaki Anzai, Tamotsu Ishizuka, Almaz Aldashev	14
16	Prognostic Value of Dual-Time-Point ¹⁸F-FDG PET for Idiopathic Pulmonary Fibrosis 2015 ·Journal of Nuclear Medicine ·Yukihiro Umeda, Yoshiki Demura, Miwa Morikawa, Masaki Anzai, Maiko Kadowaki, Shingo Ameshima, Tatsuro Tsuchida, Tetsuya Tsujikawa, Yasushi Kiyono, Hidehiko Okazawa, Takeshi Ishizaki, Tamotsu Ishizuka	36
17	18F-FDG uptake predicts diagnostic yield of transbronchial biopsy in peripheral lung cancer 2014 ·Lung Cancer ·Yukihiro Umeda, Yoshiki Demura, Masaki Anzai, Hiroki Matsuoka, Tomoyuki Araya, Masaru Nishitsuji, Koichi Nishi, Tatsuro Tsuchida, (unknown), Miwa Morikawa, Shingo Ameshima, Takeshi Ishizaki, Kazuo Kasahara, Tamotsu Ishizuka	8
18	The effects of concomitant GERD, dyspepsia, and rhinosinusitis on asthma symptoms and FeNO in asthmatic patients taking controller medications 2014 ·Journal of Asthma and Allergy ·Tamotsu Ishizuka, Takeshi Hisada, Yosuke Kamide, Haruka Aoki, (unknown), (unknown), Hiroyuki Sakai, (unknown), Yukihiro Umeda, Miwa Morikawa, Masaki Anzai, Shingo Ameshima, Takeshi Ishizaki, Masanobu Yamada, (unknown), Kunio Dobashi	10
19	Virtual Bronchoscopic Navigation Combined with Ultrathin Bronchoscopy. A Randomized Clinical Trial 2013 ·American Journal of Respiratory and Critical Care Medicine ·Fumihiro Asano, Naofumi Shinagawa, Takashi Ishida, Joe Shindoh, Masaki Anzai, Akifumi Tsuzuku, Satoshi Oizumi, Satoshi Morita	128
20	Diagnosis of peripheral pulmonary lesions using a bronchoscope insertion guidance system combined with endobronchial ultrasonography with a guide sheath 2007 ·Lung Cancer ·Fumihiro Asano, Yoshihiko Matsuno, Akifumi Tsuzuku, Masaki Anzai, Naofumi Shinagawa, Koichi Yamazaki, Takashi Ishida, Hiroshi Moriya	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact